Primary Sclerosing Cholangitis clinical trials at University of California Health

• A Study of Experimental PLN-74809 in Cholangitis and Suspected Liver Fibrosis

  open to eligible people ages 18-75

  A Phase 2a, multicenter, randomized, double-blind, dose-ranging, placebo-controlled, study to evaluate the safety, tolerability, and PK of PLN-74809 in participants with primary sclerosing cholangitis and suspected liver fibrosis

  at UC Davis UCSF

• A Study of Volixibat to Treat Itching Caused by Primary Sclerosing Cholangitis

  “Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!”

  open to eligible people ages 18 years and up

  The purpose of this clinical research study is to learn more about the use of the study medicine, volixibat, for the treatment of pruritus (itching) associated with Primary Sclerosing Cholangitis (PSC), and to assess the possible impact on the disease progression of PSC.

  at UC Davis

• Cholangioscopy in Primary Sclerosing Cholangitis (PSC)

  open to eligible people ages 18 years and up

  To demonstrate the clinical utility of the addition of per oral cholangioscopy (POCS) to standard endoscopic retrograde cholangiopancreatography (ERCP) with brushing cytology for diagnosis and early detection of cholangiocarcinoma in patients diagnosed with primary sclerosing cholangitis (PSC).

  at UC Davis

• Safety, Tolerability, and Efficacy of Cilofexor in Non-Cirrhotic Adults With Primary Sclerosing Cholangitis

  Sorry, in progress, not accepting new patients

  The primary objective of this study is to evaluate whether cilofexor reduces the risk of fibrosis progression among non-cirrhotic adults with primary sclerosing cholangitis (PSC).

  at UC Davis UCSD UCSF

Last updated: January 3, 2022